awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-2CF7A89B-00BE-4AC2-8A84-3804DE4D2C09
Q42720284-2CF7A89B-00BE-4AC2-8A84-3804DE4D2C09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-2CF7A89B-00BE-4AC2-8A84-3804DE4D2C09
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P5875
Q42720284-2CF7A89B-00BE-4AC2-8A84-3804DE4D2C09
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-2CF7A89B-00BE-4AC2-8A84-3804DE4D2C09
rank
NormalRank
type
BestRank
Statement
P5875
221709556
http://www.w3.org/2001/XMLSchema#string